Metabolomic Study for Localized Prostate Cancer

Status unconfirmed

Conditions studied: Prostate Cancer

In brief

Prostate cancer is a common disease in men treated using surgery, radiation therapy and/or hormonal therapy. Clinical prognosis relates to stage and grade of disease. Recent advances in omic analysis may offer additional information to the physician about prognosis and radiation response. We propose to establish a protocol to incorporate omic analysis into the evaluation and treatment of patients with prostate cancer.

Key facts

Study ID

NCT01968538

Run by

Georgetown University

People needed

400

Starts

2009-01-01

Expected to finish

2024-12-01

Last updated by the study team

2023-02-28

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Males who are older than 18 years old,
• with clinically localized prostate cancer
• are receiving radiation therapy

You may not qualify if…

• none

Where it is running

• Georgetown University Hospital — Arlington, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.